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Abstract We have cloned cDNAs encoding two versions of
Xenopus double-stranded RNA adenosine deaminase (ADAR1).
Like ADAR1 proteins from other species Xenopus ADAR1
contains three double-stranded RNA-binding domains (dsRBDs)
which are most likely required for substrate binding and
recognition of this RNA-editing enzyme. Analysis of mammalian
ADAR1 identified the third dsRBD in this enzyme as most
important for RNA binding. Here we analyzed the three dsRBDs
of Xenopus ADAR1 for their in vitro RNA-binding behavior
using two different assays. Northwestern assays identified the
second dsRBD in the Xenopus protein as most important for
RNA binding while in-solution assays demonstrated the im-
portance of the third dsRBD for RNA binding. The differences
between these two assays are discussed and we suggest that both
the second and third dsRBD of Xenopus ADAR1 are important
for RNA binding in vivo. We show further that all three dsRBDs
can contribute to a cooperative binding effect.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Double-stranded RNA adenosine deaminase (dsRAD,
ADAR1 or DRADA) converts adenosines to inosines in dou-
ble-stranded RNAs by deamination [1,2]. The conversion of
an adenosine to inosine in the coding region of an mRNA can
lead to the alteration of a codon as inosines are recognized as
guanosines and hence basepair with a cytosine residue present
in the anticodon of tRNA [1,3]. The enzymatic activity re-
sponsible for this base conversion was ¢rst described in Xeno-
pus embryos as an RNA-modifying and unwinding activity,
but has since been found in all metazoans tested so far [4,5].
In the last few years ADAR1 has been isolated and cloned
from rat, human, and ^ more recently ^ Xenopus [6^8].
In all cases, ADAR1 cDNAs encode proteins in the range
of 120^150 kDa. The putative translation products contain a
C-terminal deamination domain, three double-stranded RNA-
binding domains (dsRBDs) located at the center of the protein
and a relatively long N-terminal region containing a putative
Z-DNA-binding motif [9]. In addition to full length ADAR1
two shorter variants of the enzyme, termed RED-1 and RED-
2, have been isolated and cloned from rat and human [10^12].
In agreement with a new nomenclature for all adenosine de-
aminases that act on RNA, RED-1 has recently been renamed
to ADAR2 [13]. Like ADAR1, ADAR2 and RED-2 cDNAs
encode a putative deaminase region at their C-termini. How-
ever, they only contain two dsRBDs and lack most of the N-
terminal residues found in ADAR1. It also seems possible
that further members of this family of RNA adenosine deam-
inases will be isolated in the future.
ADAR1 can convert adenosines to inosines within any dou-
ble-stranded substrate but shows a 5P next-neighbor prefer-
ence. Additionally, ADAR1 activity is low at the 3P end of
an RNA [14]. Nonetheless, despite the low substrate speci¢c-
ity ADAR1 exhibits in vitro or under experimental condi-
tions, only a few in vivo candidate editing substrates for
ADAR1 are known. Potential editing substrates are the ge-
nomes of several RNA viruses which show biased hypermu-
tation most likely caused by ADAR1-mediated base conver-
sion, the kainate and AMPA glutamate-gated (GluR) ion
channel subunits and the serotonin 2C receptor [1,3,14^19].
GluR subunits are edited at several sites. The best studied
example, GluR-B subunit, is modi¢ed at three sites, the so
called Q/R site, the R/G site and a cryptic site which alters
an intron-encoded site and thus does not lead to a change in
the coding potential of the mature mRNA. Editing at the Q/
R site, however, alters the permeability of the receptor dra-
matically [20]. Most interestingly, not all three sites within
GluR-B mRNA seem to be edited by the same enzyme. In
vitro, ADAR1 can only edit the R/G site and the cryptic
intronic site while ADAR2 seems responsible for the e⁄cient
editing of the Q/R site but can also edit the R/G site
[10,17,21]. Similarly, serotonin 2C receptor can be edited at
a total of four sites, each of which can be speci¢cally modi¢ed
in vitro by either ADAR1 or ADAR2 [19].
At this point it is not known how substrate and site specif-
icity by ADAR1 and related enzymes is achieved. It seems
likely, however, that the dsRBDs are involved in the speci¢c
recognition of substrates. Speci¢c RNA recognition has also
been observed for the dsRBD containing Drosophila Staufen
protein which can recognize the 3P UTR of bicoid mRNA
[22,23]. ADAR1, like many other dsRBD proteins, contains
multiple copies of this RNA-binding motif. Interestingly, iso-
lated dsRBDs apparently fail to exhibit sequence-speci¢c
binding in vitro [24,25]. Also, data from other dsRBD pro-
teins indicate that not all dsRBDs in a given protein can bind
RNA as an isolated domain but rather contribute to a coop-
erative binding e¡ect [25,26].
It is thus possible that speci¢c RNA recognition is mediated
by these seemingly inactive dsRBDs which might require spe-
ci¢c sequences for proper RNA binding. Alternatively, RNA
recognition might be achieved by the cooperative binding and
spatial distribution of several dsRBDs within a given protein.
The dsRBDs within a protein might have to align with the
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position of double-stranded structures in a speci¢c substrate
RNA.
Analysis of human ADAR1 has identi¢ed the third dsRBD
in this protein as most important for RNA binding and enzy-
matic activity while the second dsRBD seems dispensable for
both functions [27,28]. However, alternatively spliced variants
of human ADAR1 that show minor variations in the spacer
between dsRBD-2 and 3 as well as at the end of dsRBD-3
have been identi¢ed. Mutational analyses of the dsRBDs
found in these splice variants indicate that the ¢rst and second
dsRBDs can gain importance in the context of the alterna-
tively spliced protein [29].
Similarly, an amino-terminal deletion in Xenopus
ADAR1.2, an isoform of Xenopus ADAR1, that deletes the
¢rst dsRBD still shows enzymatic activity. However, no fur-
ther analysis of the dsRBDs of Xenopus ADAR1 has been
performed to this point [8].
We have recently cloned two cDNAs encoding two variants
of Xenopus ADAR1 which are virtually identical with the
cDNAs previously published [8]. Here we report the analysis
of the three dsRBDs found in this protein. Using two di¡erent
methods to detect RNA binding we demonstrate that both the
second and third dsRBDs of Xenopus ADAR1 are important
for proper RNA binding.
2. Materials and methods
2.1. Cloning of two isoforms of Xenopus ADAR1
A partial cDNA encoding Xenopus ADAR1 had been isolated from
an expression screen for snRNA binding proteins [22,30]. The partial
cDNA was used for hybridization of the cDNA library resulting in
the isolation of two di¡erent cDNA clones both encoding a variant of
Xenopus ADAR1 [8]. Additionally, 5P ends of the two ADAR1 iso-
forms were isolated using the 5P RACE technique [31]. The isolated
clones were also tested by Northern blotting. Sequencing of our
cDNAs revealed that they are virtually identical to the ones previously
published [8].
2.2. Cloning of dsRBDs into Escherichia coli expression vectors
To allow the expression of individual dsRBDs of Xenopus ADAR1-1
the regions encoding single domains were ampli¢ed by PCR using
suitable primers. 5P primers carried a BamHI site while 3P primers
had a KpnI restriction site. Primer sequences were as follows:
dsRBD-1, 5P : TGT GGT ACC CTG CTC TTC GCG G, 3P : ATA
GGA TCC TGT CGT GCC AAG AG; dsRBD-2, 5P : AGA AGG
GAT CCA TGT GCC AGC ACA GCC AT, 3P : TTG GAG GTA
CCT TCT CAG GCT GCA GAG C; dsRBD-3, 5P : AGC GGT ACC
CTC TGC TTC ACC GAT TA, 3P : GGG GGA TCC TTA AAT
ATC TGA ATG CCA A. The PCR-ampli¢ed DNA was gel-puri¢ed,
cut with the two enzymes and ligated into either pRSET C (Invitro-
gen, La Jolla, CA, USA) cut with BamHI and KpnI or into pGEX-3
(Pharmacia, Sweden), into which a linker carrying the appropriate
restriction enzyme sites had been cloned [22].
Constructs expressing dsRBDs-1 and 2 (dsRBD-1-2), dsRBDs-2
and 3 (dsRBD-2-3) and all three dsRBDs (dsRBD-1-2-3) were also
ampli¢ed by PCR using suitable combinations of the same primers
used for cloning of the individual domains. For construct dsRBD-1-2
the 5P primer was located at the beginning of dsRBD-1 while the
3P primer was located at the end of dsRBD-2. Construct dsRBD-2-3
was ampli¢ed using primers located at the beginning of dsRBD-2
(5P primer) and at the end of dsRBD-3 (3P primer), while dsRBD-1-
2-3 was ampli¢ed with a primer at the 5P end of dsRBD-1 and one
at the end of dsRBD-3 (3P primer). PCR products were also cut
with BamHI and KpnI and ligated into pRSET C and the modi¢ed
pGEX-3 vector.
Construct dsRBD-1-3, only expressing the ¢rst and third dsRBDs
of Xenopus ADAR1.1, was made by digesting construct dsRBD-2-3
with SacI which cuts after dsRBD-2 at the beginning of the spacer
located between dsRBD-2 and dsRBD-3. The SacI site was polished
using T4 DNA-polymerase and dsRBD-2 was subsequently removed
by digestion with BamHI which cuts at the beginning of dsRBD-2.
The ¢rst dsRBD was isolated from construct dsRBD-1 by digesting
the plasmid with Asp718. The resulting cleaved ends were blunt-ended
using Klenow polymerase and dsRBD-1 was released by a second
digest with BamHI. dsRBD-1 was gel-puri¢ed and ligated into the
remaining dsRBD-3 containing vector from construct dsRBD-2-3.
After transformation candidate clones were veri¢ed by sequencing.
2.3. Northwestern assays
Northwestern assays were performed as described previously
[22,25]. Northwestern assays were quanti¢ed as described [25].
2.4. In-solution RNA-binding assays
For in-solution binding assays pRSET fusion proteins were ex-
pressed in E. coli BL21 (DE3). 50 ml cultures were inoculated with
1 ml of an overnight culture. When cultures reached an OD600=0.6
protein production was induced by addition of IPTG to 1 mM ¢nal
concentration. After 3 h of induction cells were harvested and lysed in
1UPBS, 0.1% Tween by sonication. The soluble fraction was puri¢ed
over a Ni-NTA column (Qiagen, Germany) following the manufac-
turer’s protocol. Puri¢ed protein was dialyzed against H2O containing
0.05% tri£uoroacetic acid and lyophilized.
For the binding assay 3 Wg of protein was mixed with 10 Wg of in
vitro transcribed, radiolabeled U1 snRNA in 100 Wl binding bu¡er (50
mM NaCl, 10 mM KCl, 5 mM MgCl2, 5 mM DTT, 10 mM HEPES,
pH 7.8, 3 mg/ml BSA). The mixture was incubated for 30 min at 4‡C
then shifted for 5 min to 37‡C before being ¢ltered over nitrocellulose
(BA85, Schleicher and Schuell, Germany). Filters were washed with
5 ml of 1Ubinding bu¡er without BSA, air-dried and subjected to
liquid scintillation counting. An aliquot of the in vitro transcribed U1
snRNA was counted for comparison allowing the precise quanti¢ca-
tion of the amount of bound RNA.
3. Results
3.1. Cloning of two variants of Xenopus ADAR1
From an expression screen for cDNAs that encode proteins
that bind RNA we have isolated several cDNAs encoding a
total of ¢ve di¡erent Xenopus RNA-binding proteins. We
have previously reported the characterization of one double-
stranded RNA-binding protein isolated from this screen,
called Xlrbpa [22,30]. Another group of cDNAs showed a
high degree of homology to the dsRBDs and C-terminal
end of human ADAR1 suggesting that they would encode
the Xenopus homologue of this enzyme [8].
Closer analysis of our primary cDNA clones revealed that
none of the clones contained a complete 5P end. In order to
isolate the missing 5P end of Xenopus ADAR1 we followed
two strategies. On the one hand we rescreened our library by
hybridization with probes located relatively 5P within our par-
tial cDNA clones, on the other hand we tried to obtain the
missing 5P ends following the protocol for the rapid ampli¢-
cation of cDNA ends (5P RACE) [31]. Both strategies resulted
in the isolation of two groups of cDNAs both seemingly en-
coding Xenopus homologues of human ADAR1. The 5P ends
obtained through 5P RACE were virtually identical with those
encoded by the cDNA clones isolated from the rescreen of the
library. Since the rescreen resulted in the isolation of cDNAs
containing complete open reading frames we continued our
work with the longest clones obtained from the cDNAs screen
each encoding a variant a Xenopus ADAR1.
In the meantime two cDNAs encoding Xenopus ADAR1.1
and ADAR1.2 were published by B. Bass and R. Hough [8]
and it turned out that our two cDNAs were almost identical
to the cDNAs isolated by this group. We therefore decided to
follow the previously introduced nomenclature and termed the
cDNAs isolated by us ADAR1.1 and ADAR1.2.
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Like the published Xenopus ADAR1.1 and ADAR1.2 se-
quences the putative proteins encoded by both of our cDNAs
show a high degree of homology to each other in their central
region and at their C-terminal ends but di¡er considerably at
their amino-terminal ends. Similarly, the central and C-termi-
nal ends of both putative proteins are highly homologous to
human and rat ADAR1 while the amino-terminal ends show
marked di¡erences. Also Northern blots with probes speci¢c
for our ADAR1.1 and ADAR1.2 cDNAs show signals com-
parable to those published (data not shown) [8]. It is interest-
ing to note, however, that our ADAR1.2 cDNA is lacking a
proper 5P AUG codon, just like the previously published
ADAR1.2 sequence.
3.2. Northwestern RNA-binding analysis of dsRBDs
RNA substrate recognition by ADARs is most likely medi-
ated by the three conserved dsRBDs found in this protein.
Mutagenesis studies on human ADAR1 have identi¢ed the
third dsRBD as most important for proper RNA binding
while the ¢rst dsRBD seems to contribute to RNA binding.
The second dsRBD, in contrast, seems dispensable [11,28]. In
Xenopus only a single deletion on ADAR1.2 has been ana-
lyzed which showed that the ¢rst dsRBD in this protein is not
required for enzyme function [8]. We therefore set out to
study the RNA-binding behaviors of the three dsRBDs of
Xenopus ADAR1.1 by Northwestern RNA-binding assays.
Using this assay we have previously shown that only the sec-
ond dsRBD in the Xenopus protein Xlrbpa can bind RNA as
an isolated domain while dsRBDs-1 and 3 contribute to an
overall binding e¡ect [25]. We therefore isolated the three
dsRBDs of ADAR1.1 by PCR and cloned them into the pro-
tein expression vectors pRSET and pGEX which allow the
expression of the fusion protein as 6UHis fusions or gluta-
thione S-transferase fusions, respectively. Fig. 1 shows the
predicted amino acid sequence of the expressed individual
dsRBDs. In addition, constructs expressing dsRBD-1-2,
dsRBD-2-3, dsRBD-1-3 and dsRBD1-2-3 of ADAR1.1 were
cloned into these protein expression vectors.
All proteins were expressed in E. coli, crude lysates were
separated by SDS-PAGE, blotted and tested for RNA-bind-
ing activity on a Northwestern assay [22,25]. As a positive
control for RNA binding we included the second dsRBD of
Xlrbpa. Since no speci¢c RNA substrate for Xenopus ADAR1
is known at this point Northwestern assays were performed in
parallel with two di¡erent substrates: annealed homopolymer-
ic rI/rC, and U1 snRNA. Both substrates had been used pre-
viously to determine the RNA-binding properties of Xlrbpa
[25]. Also, to determine the amount of dsRBD containing
protein in the extracts a third gel was stained with Coomassie
brilliant blue (Fig. 2).
As can be seen in Fig. 2a all constructs expressed well
allowing the clear identi¢cation of the recombinant protein
band. Of the individual domains only dsRBD-2 showed clear
binding to both radiolabeled rI/rC and U1 snRNA. Only on
longer exposures weak binding of dsRBD-3 could be detected
(data not shown). Consistent with this ¢nding was the RNA-
binding behavior of constructs expressing combinations of
dsRBDs. Here, only constructs containing dsRBD-2 showed
signi¢cant RNA binding, while the construct solely expressing
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Fig. 2. Northwestern analysis of individual dsRBDs and combinato-
rial constructs. Coomassie-stained gel (a) and RNA-binding assay
performed with U1 snRNA (b) or rI/rC-RNA (c) of dsRBD con-
structs. Xl2 expresses the second dsRBD of Xenopus Xlrbpa as a
positive control. Constructs dsRBD-1, dsRBD-2 and dsRBD-3 ex-
press only single dsRBDs while constructs dsRBD-1-2, dsRBD-2-3
and dsRBD-1-3 express two dsRBDs. Construct dsRBD-1-2-3 ex-
presses all three dsRBDs. Arrows mark the position of proteins
containing two or all three dsRBDs in the Coomassie-stained gel.
Only constructs expressing dsRBD-2 alone or in combination with
other dsRBDs exhibit strong RNA binding. A faint signal, indicat-
ing weak RNA binding, can be observed for construct dsRBD-1-3.
Construct 1-2-3 shows reduced RNA binding when compared to
construct dsRBD-1-2, indicating that the third dsRBD can nega-
tively interfere with RNA binding. Also, several lower molecular
weight bands can be observed in lane dsRBD-1-2-3 which are
breakdown products of the full-length protein.
Fig. 1. Alignment of the three dsRBDs found in Xenopus ADAR1.1. Amino acid sequence of the tree dsRBDs is given in single-letter code.
Numbers refer to the position of the ¢rst amino acid in Xenopus ADAR1.1. Capital letters mark amino acids found in at least two of the three
dsRBDs while bold letters indicate amino acids found in the dsRBD consensus sequence. The dsRBD consensus sequence is given below.
# marks hydrophobic residues.
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dsRBDs-1 and 3 showed almost no RNA binding (Fig. 2).
Also, constructs expressing combinations of active and inac-
tive dsRBDs (dsRBD-1-2 and dsRBD-2-3) showed stronger
binding than the isolated dsRBD-2 alone indicating that the
inactive dsRBDs can contribute to overall RNA binding and
thus exhibit a cooperative binding e¡ect. It is also interesting
to note that dsRBD-2 of ADAR1.1 shows stronger binding to
U1 snRNA than to rI/rC when compared to the binding of
Xl2 which showed comparable binding of both substrates.
To get a clearer view of the subtle di¡erences exhibited by
the various constructs the autoradiograms were quanti¢ed
using a Phosphoimager and the amounts of overexpressed
proteins were determined by laser densitometry. Furthermore,
to determine the molar amount of RNA bound per mol of
protein some reference bands from the Northwestern blot
were cut out and quanti¢ed by scintillation counting. Using
these data we calculated the molar amounts of each RNA
substrate bound per mol of each protein (Fig. 3).
As can be seen RNA binding of all constructs is relatively
weak as only micromolar amounts of RNA are bound per
mol of protein. Furthermore, binding of U1 was generally
weaker than binding of rI/rC, with the exception of dsRBD-
2 which showed slightly stronger binding to U1 snRNA. The
generally stronger binding of rI/rC can most likely be ex-
plained by the perfect double-stranded nature of this an-
nealed, homopolymeric RNA. Binding of hybrid constructs
dsRBD-1-2 and dsRBD-2-3 was 14^40-fold stronger than
that of dsRBD-2 alone depending on the substrate used.
However, binding of construct dsRBD-2-3 was weaker than
binding of construct dsRBD-1-2 when rI/rC was used as a
substrate while almost identical binding values were obtained
for both constructs with U1. The Phosphoimager data also
revealed some minor binding of dsRBD-3 alone which was
not detected on the autoradiograms. Similarly, combination
of domains 1 and 3 (dsRBD-1-3) revealed binding comparable
to that of domain 2 (in molar terms) suggesting that both
domains can contribute to RNA binding when expressed in
combination with another dsRBD. Interestingly, expression of
all three domains (dsRBD-1-2-3) showed weaker binding than
either constructs dsRBD-1-2 or dsRBD-2-3 indicating that
dsRBD-3 can also negatively in£uence RNA binding. Taken
together, the Northwestern analysis identi¢ed the second
dsRBD of ADAR1.1 as most important for RNA binding.
3.3. In-solution binding of Xenopus ADAR1.1 dsRBDs
Previous studies on human ADAR1 have identi¢ed the
third dsRBD in this protein as most important for RNA bind-
ing and enzymatic activity [11,28]. Additionally, the ¢rst
dsRBD has been shown to contribute to both processes while
the second dsRBD seemed almost dispensable [11,28]. This is
in clear contrast with our observation that identi¢ed the sec-
ond dsRBD of Xenopus ADAR1.1 as most important for
RNA binding. However, not only the proteins investigated
in these studies di¡ered but also the assays employed to de-
termine RNA binding. While our study relied on a North-
western assay where immobilized protein is refolded by treat-
ment with chaotropic agents and subsequently incubated with
substrate RNA, analyses of human ADAR1 were done by a
solution binding assay where either overexpressed or in vitro
translated protein is incubated in solution with substrate
RNA and subsequently ¢ltered over nitrocellulose to deter-
mine the amount of bound RNA.
We therefore repeated our analysis of individual dsRBDs of
Xenopus ADAR1 using an in-solution RNA-binding assay.
To do this, the individual domains of Xenopus ADAR1.1
and the second dsRBD of Xlrbpa were expressed in E. coli
as 6UHis fusion proteins and puri¢ed by Ni-chelating a⁄nity
chromatography. When the puri¢ed proteins were used for in-
solution binding assays a completely di¡erent picture emerged
(Fig. 4). The in-solution assay identi¢ed the third dsRBD of
Xenopus ADAR1.1 as the most actively RNA-binding domain
while both dsRBD-1 and dsRBD-2 showed almost no RNA
binding. However, RNA binding of dsRBD-2 was generally
somewhat stronger than that of dsRBD-1. Also, RNA bind-
ing of all constructs was stronger in solution than in North-
western assays as millimolar rather than micromolar amounts
of RNA were bound per mol of protein in this assay.
Identi¢cation of the third dsRBD in Xenopus ADAR1 is in
good agreement with studies on human ADAR1 which too
identi¢ed the third domain in this protein as most important
for RNA binding. However, the in-solution assay is in clear
contrast to our Northwestern studies where the second
dsRBD seemed most important for RNA binding.
Northwestern assays rely on the proper refolding of pro-
teins that have been blotted onto membranes after separation
on an SDS-PAGE. To facilitate refolding, the membranes are
treated with chaotropic agents such as urea or guanidinium
hydrochloride and subsequently incubated in a stepwise dilu-
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Fig. 3. Quantitation of RNA-binding activity of dsRBD-expressing
constructs by Northwestern assays. Overexpressed proteins were
quanti¢ed by laser densitometry on Coomassie-stained gels and
RNA binding was measured on a Phosphoimager and by liquid
scintillation counting. The molar amounts of RNA bound were nor-
malized to the molar concentration of each dsRBD construct. Light
gray bars indicate amount of U1 snRNA bound while dark gray
bars represent rI/rC binding. Hybrid constructs dsRBD-1-2 and
dsRBD-2-3 show 10^40-fold increased RNA binding when com-
pared to dsRBD-2 alone, indicating a strong cooperative binding ef-
fect. In contrast, construct dsRBD-1-3 shows only a moderate in-
crease in RNA binding demonstrating the importance of dsRBD-2
for RNA binding. A construct containing all three dsRBDs of Xen-
opus ADAR1.1 (dsRBD-1-2-3) shows reduced RNA binding when
compared to the two-domain constructs containing dsRBD-2. In
most cases RNA-binding to rI/rC is stronger than binding to U1
snRNA which is probably due to the perfect double-stranded nature
of this homopolymeric synthetic substrate.
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tion series of the chaotropic agent in a physiological bu¡er.
The slow renaturation has been shown to facilitate correct
folding of several proteins [32,33]. In contrast, the in-solution
assay uses proteins overexpressed and puri¢ed from various
sources or in vitro translated proteins and does not employ
any refolding step. As E. coli-expressed proteins also tend to
misfold it seemed conceivable that the di¡erences observed in
the two assays resulted from misfolding of various constructs
in either assay.
To test this possibility we subjected the puri¢ed, E. coli-
produced proteins used in the in-solution assay to a denatu-
ration and refolding step. Urea was added to the puri¢ed
proteins to a ¢nal concentration of 8 M. After denaturation,
the proteins were subjected to slow dialysis for 24 h against
stepwise dilutions of urea in TBS. This treatment should also
lead to a slow renaturation of the puri¢ed proteins thus al-
lowing their proper folding. However, RNA binding of the
refolded proteins was generally comparable to that of the un-
treated ones. Again, dsRBD-3 and Xl2 showed the strongest
RNA binding while dsRBDs-1 and 2 were almost inactive
(Fig. 4). RNA binding of refolded Xl2 and dsRBD-3 was
somewhat weaker than that of the corresponding native pro-
teins. Taken together these data suggest that the observed
di¡erences in RNA binding of constructs tested in the two
assays employed are not simply caused by the refolding of
proteins. Instead, other factors such as the interaction of pro-
teins with the membrane might in£uence folding.
4. Discussion
Double-stranded RNA adenosine deaminase (dsRAD,
DRADA-1 or ADAR-1) converts adenosines to inosines in
double-stranded RNA by hydrolytic deamination [1,2]. The
enzyme has been implemented in the editing of certain sub-
units of glutamate-gated ion channels and serotonin receptor
2C in mammalian brain. Also some RNA viruses seem suit-
able substrates for ADAR1 [1,3]. cDNAs encoding ADAR1
have been cloned from mammals and, more recently, Xenopus
[6^8]. The proteins encoded by these cDNAs all have a con-
served deaminase domain at their C-terminus and three dou-
ble-stranded RNA-binding domains in their central region.
However, considerable variability is observed at the amino-
terminal ends of the putative proteins.
Substrate recognition by ADAR1 is most likely achieved
through the three centrally located dsRBDs. Studies on hu-
man ADAR1 have identi¢ed the third dsRBD in this protein
as most important for RNA binding and enzyme function
[27,28].
In this study we have analyzed the three dsRBDs of Xeno-
pus ADAR1.1 by Northwestern and in-solution assays for
their dsRNA-binding behavior. Our Northwestern analysis
revealed that the second dsRBD is most important for
RNA binding both when expressed as an isolated domain
and in combination with other dsRBDs. We could show fur-
ther that domains showing little or no RNA binding by them-
selves can contribute to overall RNA binding when expressed
in combination with another dsRBD. Similar e¡ects have also
been observed for PKR, Xenopus Xlrbpa and human ADAR1
where domains incapable of RNA binding could exhibit a
cooperative binding e¡ect [24,25,27,28,34].
In-solution assays, on the other hand, identi¢ed the third
dsRBD of ADAR1.1 as the most active one while dsRBD-2
seemed almost completely inactive in this assay. This latter
datum is in good agreement with studies on human ADAR1
which also identi¢ed the third dsRBD as most important for
RNA binding and enzyme activity. However, all studies on
mammalian ADAR1 were also performed by in-solution as-
says.
While it is possible that both Northwestern and in-solution
binding assays lead to false-positive signals, several arguments
make us believe that the opposite is the case, namely that
some domains fail to show RNA binding in either assay.
First, the second dsRBD of Xlrbpa (Xl2) shows RNA bind-
ing in both assays (Figs. 2 and 4) [25] indicating that the two
assays can give identical results. Second, studies performed on
the double-stranded RNA-dependent, interferon-activated
kinase PKR have identi¢ed the ¢rst dsRBD in this protein
as most important for RNA binding both by Northwestern
and in-solution assays, demonstrating again that both assays
can give comparable results [35,26,36]. Third, studies on hu-
man ADAR1 expressed and puri¢ed from COS cells identi¢ed
all three domains as important for RNA- diting, indicating
that all domains are important at least for enzyme activity
[29]. Furthermore, Northwestern assays have been used to
identify actively binding dsRBDs in several other proteins.
Finally, the data obtained from the Northwestern assays iden-
tify the second dsRBD as RNA binding not only when ex-
pressed as an isolated domain but also when in context with
other dsRBDs, indicating that the context of the domain
which can also in£uence folding does not in£uence the
RNA-binding activity of dsRBD-2 in this assay. Similarly,
identical results were obtained when proteins were expressed
as 6UHis or GST fusions, again indicating that the context of
the protein did not in£uence the outcome of the experiment.
The di¡erences observed in the two assays are thus most
likely the result of di¡erent folding of individual constructs in
the two assays. All in vitro RNA-binding assays rely on the
proper folding of proteins. It has been shown that E. coli-
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Fig. 4. In-solution RNA binding of individual dsRBDs. Individual
dsRBDs of ADAR1.1 were expressed as His-fusion protein and pu-
ri¢ed by Ni-chelating chromatography. Puri¢ed proteins were al-
lowed to bind to radiolabeled U1 snRNA in solution and ¢ltered
over nitrocellulose disks. The amount of bound RNA was deter-
mined by liquid scintillation counting and normalized to the molar
amount of protein. Light gray bars are the results of binding to ‘na-
tive’ E. coli-produced proteins. Dark gray bars indicate binding of
U1 snRNA to refolded E. coli-produced proteins. Only the third
dsRBD of Xenopus ADAR1.1 shows signi¢cant RNA binding while
dsRBDs-1 and 2 show binding values comparable to background
binding to the ¢lter. Refolding of the protein does not in£uence the
in-solution binding behavior of the constructs although binding of
refolded proteins was generally reduced when compared with native
proteins.
R. Brooks et al./FEBS Letters 434 (1998) 121^126 125
produced proteins tend to misfold [32,37]. It is therefore pos-
sible that the second dsRBD which does not show any activity
in solution but shows considerable RNA-binding activity in
Northwestern assays fails to fold properly when expressed in
E. coli. Similarly, all proteins tested by Northwestern are de-
natured during SDS-PAGE. Proper folding of the proteins is
believed to be achieved by denaturation of membrane-bound
proteins following slow renaturation which should allow re-
folding of the proteins [32]. This treatment in turn might lead
to misfolding of dsRBD-3 while facilitating proper folding of
dsRBD-2 which proved to be RNA binding in our Northwest-
ern experiments. Interestingly, refolding by itself does not lead
to activation of dsRBD-2 as urea treatment and subsequent
dialysis of puri¢ed dsRBD-2 does not lead to RNA-binding
activity of this domain in solution. We therefore believe that
interaction of the protein with the membrane is required for
RNA binding. Ionic interactions between the membrane and
protein might alter folding thus helping to expose certain
amino acids which are required for RNA binding. In solution,
certain amino acids or regions within dsRBD-2 might be
buried at least in some cases, thus leading to false inactivity
of an otherwise active domain.
The importance of the second dsRBD in ADAR1 is also
underscored by a study on alternatively spliced variants of
human ADAR1 which showed that mutations in the second
dsRBD of this protein can have di¡erent e¡ects on enzyme
activity in alternatively spliced versions of the enzyme [29].
Similarly, we could show recently that the second dsRBD of
ADAR1.1 is required for proper localization of the protein on
nascent transcripts on Xenopus lampbrush chromosomes,
again indicating the importance of this dsRBD (Eckmann
and Jantsch, in preparation). In vivo, interactions with other
proteins particularly chaperones might help to fold all RNA-
binding domains into an actively binding form. This view is
also supported by the ¢nding that all three dsRBDs contrib-
ute to maximum enzyme activity of human ADAR1 overex-
pressed in COS cells [29]. Taken together, we therefore believe
that both domains identi¢ed in our study are required for
proper RNA binding. In fact, given the high degree of con-
servation of all dsRBDs amongst the ADAR1 homologues
identi¢ed thus far, it appears very likely that all three dsRBDs
play a role in active RNA binding in vivo. However, further
in vivo studies will be required to clarify this point.
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